Article
hptA Mutation May Mediate Fosfomycin Resistance in Methicillin-Resistant Staphylococcus aureus Clinical Isolates.
Microbial drug resistance (Larchmont, N.Y.) - 1 Nov 2023
Wang Jue, Xu Xiaogang, Zhao Xiaoyu, Xu Su, Wang Minggui
Abstract excerpt
Fosfomycin can be used alone or in combination to treat methicillin-resistant Staphylococcus aureus (MRSA) infection. However, fosfomycin resistance has been observed in MRSA. In S. aureus, fosfomycin resistance is mediated by the fosfomycin-modifying enzyme FosB, or mutations in the target enzyme MurA. Mutations in the chromosomal glpT and uhpT genes, which encode fosfomycin transporters, also result in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
